USA - engelsk - NLM (National Library of Medicine)

inspec solutions llc. - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - uses helps relieve anorectal symptoms (pain, soreness, burning, itching). temporarily reduces the swelling associated with irritated hemorrhoidal tissue and other anorectal disorders. stop use and ask doctor if • condition worsens, or if symptoms persist for more than 7 days, or dear up and reoccur again within a few days. do not use if pregnant or breast-feeding. directions • adults and children 2 years of age and older: apply to affected area not more than 3 to 4 times daily. • children under 2

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - mycophenolate mofetil 250mg;   - capsule - 250 mg - active: mycophenolate mofetil 250mg   excipient: croscarmellose sodium gelatin magnesium stearate povidone pregelatinised maize starch - cellcept is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. cellcept is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - mycophenolate mofetil 500mg (as 542 mg of the hydrochloride salt);   - powder for infusion - 500 mg - active: mycophenolate mofetil 500mg (as 542 mg of the hydrochloride salt)   excipient: citric acid polysorbate 80 sodium chloride - cellcept is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. cellcept is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - mycophenolate mofetil 200 mg/ml;   - powder for oral suspension - 200 mg/ml - active: mycophenolate mofetil 200 mg/ml   excipient: aspartame citric acid colloidal silicon dioxide fruit mix flavour 274869 lecithin methyl hydroxybenzoate sodium citrate dihydrate sorbitol xanthan gum - cellcept is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. cellcept is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - mycophenolate mofetil 500mg;   - tablet - 500 mg - active: mycophenolate mofetil 500mg   excipient: croscarmellose sodium magnesium stearate microcrystalline cellulose opadry lavender y-5-10272-a povidone - cellcept is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. cellcept is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.

Singapore - engelsk - HSA (Health Sciences Authority)

roche singapore pte. ltd. - mycophenolate mofetil - injection, powder, for solution - 500 mg/vial - mycophenolate mofetil 500 mg/vial

Singapore - engelsk - HSA (Health Sciences Authority)

roche singapore pte. ltd. - mycophenolate mofetil - tablet, film coated - 500 mg - mycophenolate mofetil 500 mg

Singapore - engelsk - HSA (Health Sciences Authority)

roche singapore pte. ltd. - mycophenolate mofetil - capsule - 250 mg - mycophenolate mofetil 250 mg

Armenia - engelsk - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

f. hoffmann-la roche ltd. - mycophenolate mofetil - capsules - 250mg

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

roche products ltd - mycophenolate mofetil hydrochloride - powder for solution for infusion - 500mg